Author:
Morito Naoki,Yoh Keigyou,Usui Toshiaki,Oishi Hisashi,Ojima Masami,Fujita Akiko,Koshida Ryusuke,Shawki Hossam H.,Hamada Michito,Muratani Masafumi,Yamagata Kunihiro,Takahashi Satoru
Reference46 articles.
1. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease- Mineral and Bone Disorder (CKD-MBD);Kidney Int Suppl,2009
2. FGF-23 and secondary hyperparathyroidism in chronic kidney disease;Silver;Nat Rev Nephrol,2013
3. MafB, a new Maf family transcription activator that can associate with Maf and Fos but not with Jun;Kataoka;Mol Cell Biol,1994
4. Maf nuclear oncoprotein recognizes sequences related to an AP-1 site and forms heterodimers with both Fos and Jun;Kataoka;Mol Cell Biol,1994
5. MafB interacts with Gcm2 and regulates parathyroid hormone expression and parathyroid development;Kamitani-Kawamoto;J Bone Miner Res,2011